CTL inducing vaccines, recombinant adeno-associated virus vaccine and modified vaccinia Ankara are being developed for:-
CTL inducing vaccines, recombinant adeno-associated virus vaccine and modified vaccinia Ankara are being developed for HIV/AIDS. Since 1987, more than 30 HIV candidate vaccines have been tested in clinical trials phases I/II: some of them are: AIDS VAX; only vaccine in phase III trials. Cytotoxic T-Lymphocytes inducing vaccine. Recombinant adeno-associated virus vaccine. Modified vaccine Ankara vaccine. Subunit vaccine.
Tuberculosis
Leprosy
Malaria
HIV/AIDS
NPCBVI, NACP